Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Clinical trial NCT00550459 · COMPLETED
Trial details
- NCT number
- NCT00550459
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-02-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.